Cite
Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis.
MLA
Choy, Ernest, et al. “Effects of Concomitant Glucocorticoids in TOZURA, a Common-Framework Study Programme of Subcutaneous Tocilizumab in Rheumatoid Arthritis.” Rheumatology, vol. 58, no. 6, June 2019, pp. 1056–64. EBSCOhost, https://doi.org/10.1093/rheumatology/key393.
APA
Choy, E., Caporali, R., Xavier, R., Fautrel, B., Sanmarti, R., Bao, M., Devenport, J., & Pethö-Schramm, A. (2019). Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis. Rheumatology, 58(6), 1056–1064. https://doi.org/10.1093/rheumatology/key393
Chicago
Choy, Ernest, Roberto Caporali, Ricardo Xavier, Bruno Fautrel, Raimon Sanmarti, Min Bao, Jenny Devenport, and Attila Pethö-Schramm. 2019. “Effects of Concomitant Glucocorticoids in TOZURA, a Common-Framework Study Programme of Subcutaneous Tocilizumab in Rheumatoid Arthritis.” Rheumatology 58 (6): 1056–64. doi:10.1093/rheumatology/key393.